Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen L Poston

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
PET Clinics|August 7, 2010
FDG PET in the Evaluation of Parkinson's DiseaseKathleen L Poston, David Eidelberg
Neurobiology of Disease|November 18, 2008
Network biomarkers for the diagnosis and treatment of movement disordersKathleen L Poston, David Eidelberg
Seminars in Neurology|March 20, 2023
Cognitive Impairment in Neurodegenerative Movement DisordersCarla Abdelnour, Kathleen L Poston
Neuroimage|December 31, 2011
Functional brain networks and abnormal connectivity in the movement disordersKathleen L Poston, David Eidelberg
Expert Opinion on Pharmacotherapy|October 13, 2007
Zydis selegiline in the management of Parkinson's diseaseKathleen L Poston, Cheryl Waters
Journal of Clinical Movement Disorders|January 21, 2016
What light have resting state fMRI studies shed on cognition and mood in Parkinson's disease?Sophie YorkWilliams, Kathleen L Poston
Neuropsychology Review|December 3, 2015
Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic ReviewKatherine Leaver, Kathleen L Poston
Parkinsonism & Related Disorders|October 21, 2019
MRI biomarkers of motor and non-motor symptoms in Parkinson's diseaseSephira G Ryman, Kathleen L Poston
Parkinsonism & Related Disorders|December 10, 2017
Further study of the Montreal Cognitive Assessment's domain-specific metrics could allow for international data comparison and collaborationTaylor R Hendershott, Kathleen L Poston
Journal of Neurology|November 19, 2008
Movement disorder emergenciesKathleen L Poston, Steven J Frucht
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
PET Clinics|August 7, 2010
FDG PET in the Evaluation of Parkinson's DiseaseKathleen L Poston, David Eidelberg
Neurobiology of Disease|November 18, 2008
Network biomarkers for the diagnosis and treatment of movement disordersKathleen L Poston, David Eidelberg
Seminars in Neurology|March 20, 2023
Cognitive Impairment in Neurodegenerative Movement DisordersCarla Abdelnour, Kathleen L Poston
Neuroimage|December 31, 2011
Functional brain networks and abnormal connectivity in the movement disordersKathleen L Poston, David Eidelberg
Expert Opinion on Pharmacotherapy|October 13, 2007
Zydis selegiline in the management of Parkinson's diseaseKathleen L Poston, Cheryl Waters
Journal of Clinical Movement Disorders|January 21, 2016
What light have resting state fMRI studies shed on cognition and mood in Parkinson's disease?Sophie YorkWilliams, Kathleen L Poston
Neuropsychology Review|December 3, 2015
Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic ReviewKatherine Leaver, Kathleen L Poston
Parkinsonism & Related Disorders|October 21, 2019
MRI biomarkers of motor and non-motor symptoms in Parkinson's diseaseSephira G Ryman, Kathleen L Poston
Parkinsonism & Related Disorders|December 10, 2017
Further study of the Montreal Cognitive Assessment's domain-specific metrics could allow for international data comparison and collaborationTaylor R Hendershott, Kathleen L Poston
Journal of Neurology|November 19, 2008
Movement disorder emergenciesKathleen L Poston, Steven J Frucht
Pageof 16